Novartis Investigative site
East Hanover, New Jersey 79361080
2 studies enrolling now · 39 studies all time
What they study most
Acute Lymphoblastic Leukemia (ALL), Age-related Macular Degeneration (AMD), Allergic Asthma, C3 Glomerulopathy, Chronic Heart Failure, Chronic Myeloid Leukemia, Diabetes Mellitus, Type 2, Diffuse Large B-Cell Lymphoma (DLBCL), Diffuse Large B-cell Lymphoma, Diffuse Large B-cell Lymphoma (DLBCL), Healthy, Heart Failure
Studies at this site
- Home Reported Outcomes in PNH — Recruiting now
- Home Reported Outcomes in C3G Study — Recruiting now
- Concept Elicitation and Patient Experience Mapping in SA-AKI — Completed
- Multiple Sclerosis Patient Experience on Kesimpta and Ocrevus Subcutaneous Formulation — Completed
- WOE of Anti-CD20 Therapies — Completed
- Health-related Quality of Life, Symptom Severity, and Pain Among Patients With PIK3CA-related Overgrowth Spectrum: A Mixed-methods Observational Study — Completed
- A Survey to Evaluate Early Experience From Patient and Care Partner on Injection and Device for KESIMPTA® Indicated for Multiple Sclerosis — Completed
- Clinical Outcomes of 3L+ Therapies Among Patients With Chronic Myeloid Leukemia and Those With T315I Mutation — Completed
- Treatment Patterns and Outcomes of Targeted Therapy and Immunotherapy Among BRAF-Positive Melanoma Patients Treated in the Adjuvant Setting and Among BRAF-Positive Metastatic Melanoma Patients With Low Tumor Burden — Completed
- Sacubitril/Valsartan Treated Adult Patients With Chronic Heart Failure — Completed
- Study Conducted Among Patients With CML — Completed
- Characteristics of Patients With Sickle Cell Disease — Completed
- Characterization of Early Patients Initiating Ofatumumab for Treatment of Multiple Sclerosis. — Completed
- Risk Perception in Multiple Sclerosis — Completed
- Comparison of Clinical Outcomes Among Patients Treated With Tisagenlecleucel — Completed
- Effectiveness and Safety of Omalizumab in Children With Allergic Asthma. — Completed
- Ruxolitinib for Polycythemia Vera in Patients Resistant to or Intolerant of Hydroxyurea. — Completed
- Real-world Resource Use and Costs of CAR-T Therapies in Diffuse Large B-cell Lymphoma (DLBCL) — Completed
- Evaluation of the Effectiveness of Secukinumab in Patients With Moderate to Severe Plaque Psoriasis — Completed
- Treatment Effectiveness Among Psoriasis Patients Treated With Cosentyx (Secukinumab) — Completed
- CAR T Cells Real World Evidence Study Based on the French Hospital Claims Data Source (PMSI) — Completed
- An Analysis of the Improvement and Quality of Life Trends for UK/ROI Patients Treated With Cosentyx (Secukinumab) in a Retrospective Analysis of the BADBIR Data Source — Completed
- Real-world Impact of Erenumab on Sick-leaves, Health Care Resource Use and Comorbidities. — Completed
- Healthcare Costs and Resource Utilization in Aimovig Migraine Patients: a Retrospective Study Using United States Claims Data — Completed
- Real-world Evaluation of Prevalence of Ocular Adverse Events in Patients With Neovascular (Wet) Agerelated Macular Degeneration (AMD) Who Received Anti-VEGF Agents (IRIS Registry) — Completed
- Description of Treatment Patterns and Description and Comparison of Healthcare Resource Utilization and Costs of Women With Metastatic HR+/HER2- Breast Cancer Treated With CDK4/6 Inhibitors — Completed
- A Cohort Study to Compare the Hospitalization Between Naive Sacubitril/Valsartan and Naive ACEi/ARBs Heart Failure Patients With Reduced Ejection Fraction Using Secondary US Electronic Health Records Data — Completed
- Real-world Evaluation of Brolucizumab for the Treatment of Neovascular (Wet) Age-related Macular Degeneration (AMD) (Komodo Health) — Completed
- Real-world Evaluation of Prevalence of Ocular Adverse Events in Patients With Neovascular (Wet) Age-related Macular Degeneration (AMD) Who Received Anti-vascular Endothelial Growth Factor (VEGF) Agents (Komodo Health) — Completed
- Characteristics of Patients With Neovascular Age-related Macular Degeneration Enrolled in the Brolucizumab Patient Support Services Program — Completed
- Extension to a Study on the Efficacy and Safety of Vildagliptin Compared to Metformin in Drug Naive Patients With Type 2 Diabetes — Completed
- Liver Fibrosis in Patients Transplanted for Hepatitis C Receiving Either Cyclosporine Microemulsion or Tacrolimus — Stopped early
- Safety, Pharmacodynamic and Pharmacokinetic Effects of QAX576 in Healthy Volunteers. — Completed
- Effects of FTY720 on Heart and Lung Functions in Healthy Volunteers — Completed
- Safety, Tolerability, Pharmacodynamic and Pharmacokinetic Effects of Single and Multiple-Doses of ATF936 and AXT914 Administered Orally in Healthy Subjects. — Completed
- Safety and Pharmacokinetics of Indacaterol in Healthy Subjects and Those With Impaired Liver Function — Completed
- Safety and Pharmacokinetic Effects of Oseltamivir Alone or in Combination With Amantadine — Completed
- Bioavailability of Aliskiren and Valsartan as a Single Tablet vs. the Same Doses of the Two Drugs Given Separately to Healthy Subjects. — Completed
- Bioavailability of Aliskiren and Valsartan Combined as a Single Tablet vs. the Same Medications Given Separately to Healthy Subjects. — Completed